Augmentation of clozapine partial responders with conventional antipsychotics [3]

Schizophrenia Research

Volumn 60, Issue 1, 2003, Pages 97-98

  Rajarethinam, Rajaprabhakaran ^a   Gilani, Sadia ^a   Tancer, Manuel ^a   DeQuardo, John ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Colorado Mental Health Institute at Pueblo   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL DECANOATE; NEUROLEPTIC AGENT; SEROTONIN 2A ANTAGONIST;

ADULT; CASE REPORT; CLINICAL FEATURE; DOPAMINE RELEASE; DRUG EFFECT; HUMAN; LETTER; MALE; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG SYNERGISM; FLUPHENAZINE; HALOPERIDOL; HUMANS; MIDDLE AGED; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0037333115     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(02)00293-1     Document Type: Letter

References (6)

1. Kapur S., Meltzer H.Y. Pro/con serotonin and atypicality. J. Psychotic Disord. vol. 3:2001;. April.
2. Kapur S., Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics? A new hypothesis. Am. J. Psychiatry. 158(3):2001;360-369. Mar, Review.
3. Kapur S., Roy P., Daskalakis J., Remington G., Zipursky R. Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine. Am. J. Psychiatry. 158(2):2001;311-314. Feb.
4. Kuroki T., Meltzer H.Y., Ichikawa J. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J. Pharmacol. Exp. Ther. 288:1999;774-781.
5. Mowerman S., Siris S.G. Adjunctive loxapine in a clozapine-resistant cohort of schizophrenic patients. Ann. Clin. Psychiatry. 8:1996;193-197.
6. Rush, A.J., Rage, W.V., Crimson, M.L., et al., 1999. Medication treatment for the severely and persistently mentally ill: Texas medication algorithm project. 60, 284-291.